Olanzapine represents a second-generation atypical antipsychotic agent approved for the treatment of psychotic disorders, schizophrenia, schizoaffective disorders, mania and other conditions with psychotic components. As
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
